Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591165 | SCV000704707 | uncertain significance | not provided | 2016-12-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000591165 | SCV001097576 | benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001449946 | SCV001653436 | likely benign | X-linked Alport syndrome | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000591165 | SCV001753491 | likely benign | not provided | 2020-02-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000591165 | SCV004167394 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | COL4A5: BP4, BS2 |
Natera, |
RCV001449946 | SCV002081358 | likely benign | X-linked Alport syndrome | 2019-10-28 | no assertion criteria provided | clinical testing |